Manipal Health Enterprises, one of India's leading private hospital chains, has secured approval from the Securities and Exchange Board of India (SEBI) for its proposed initial public offering (IPO). This development marks a significant milestone for the Bengaluru-based company, which operates 49 multi-specialty hospitals across 24 cities in India. In addition to the fresh issue of shares, existing investors plan to sell over 43.2 million shares, representing a 3.66% stake in the company. This combined offering is likely to value Manipal Health at between $8.0 to $8.5 billion, according to sources familiar with the matter.
The funds raised from the IPO are intended to support Manipal Health's expansion plans and to repay existing debts. Notably, the company acquired the Sahyadri Hospitals chain for approximately ₹6,400 crore in 2025, utilizing a line of credit from KKR’s insurance business. A significant portion of the IPO proceeds is expected to be allocated towards repaying this debt.
Founded in 2010, Manipal Health has rapidly expanded its footprint in the Indian healthcare sector. The company offers a wide range of medical services, including cardiology, oncology, transplants, neurosciences, orthopaedics, emergency, and critical care. Its network spans cities such as Bengaluru, Mangaluru, Mysore, Vijayawada, Salem, Dwarka, Palamvihar, Goa, Jaipur, Ghaziabad, Patiala, Pune, and Kolkata.
In April 2023, Singapore's Temasek acquired a 41% stake in Manipal Health for over $2 billion, valuing the company at nearly $4.8 billion. This investment increased Temasek's total shareholding to approximately 59%, with Manipal Education and Medical Group Pvt. Ltd retaining around 31% and TPG holding about 10-11%.
The approval of Manipal Health's IPO by SEBI paves the way for one of India's largest healthcare listings in recent years. The company is targeting a stock market debut by the end of July or early August 2026. This move comes at a time when the Indian IPO market is witnessing a slowdown due to geopolitical uncertainties and foreign investor outflows. However, the healthcare sector continues to attract significant interest, with rising demand for complex care services.
Manipal Health's IPO is poised to be a landmark event in India's healthcare industry, reflecting the sector's growth and the increasing investor confidence in its potential. The successful listing of the company could set a precedent for future healthcare IPOs in the country, highlighting the viability and attractiveness of healthcare investments in India's dynamic market.